Published in Ann Neurol on March 01, 2007
The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc Natl Acad Sci U S A (2007) 3.11
Hereditary spastic paraplegias: membrane traffic and the motor pathway. Nat Rev Neurosci (2011) 2.30
The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiol Rev (2012) 1.95
The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation. Diabetes (2008) 1.67
Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J Biol Chem (2009) 1.44
A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover. J Cell Biol (2009) 1.30
Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis. J Lipid Res (2011) 1.14
Seipin: from human disease to molecular mechanism. J Lipid Res (2012) 1.12
Seipin is a discrete homooligomer. Biochemistry (2010) 1.09
Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology (2008) 0.97
Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation. Muscle Nerve (2013) 0.85
Towards a mechanistic understanding of lipodystrophy and seipin functions. Biosci Rep (2014) 0.85
A novel 16p locus associated with BSCL2 hereditary motor neuronopathy: a genetic modifier? Neurogenetics (2009) 0.83
Neuroanatomical characterisation of the expression of the lipodystrophy and motor-neuropathy gene Bscl2 in adult mouse brain. PLoS One (2012) 0.78
Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy. Diabetol Metab Syndr (2016) 0.77
Seipin/BSCL2 mutation screening in sporadic adult-onset upper motor neuron syndromes. J Neurol (2009) 0.77
Motor neuron degeneration in a mouse model of seipinopathy. Cell Death Dis (2013) 0.76
Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS). J Biol Chem (2012) 0.76
Clinical and Molecular Characterization of BSCL2 Mutations in a Taiwanese Cohort with Hereditary Neuropathy. PLoS One (2016) 0.75
Skipped BSCL2 Transcript in Celia's Encephalopathy (PELD): New Insights on Fatty Acids Involvement, Senescence and Adipogenesis. PLoS One (2016) 0.75
ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia. J Neurol (2016) 0.75
Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol (2009) 2.42
Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet (2011) 2.26
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain (2012) 2.18
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial. J Hypertens (2011) 1.75
Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol (2010) 1.71
The MG-QOL15 Japanese version: validation and associations with clinical factors. Muscle Nerve (2012) 1.65
Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death. J Biol Chem (2004) 1.63
Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab (2008) 1.59
Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Neurology (2011) 1.55
Contribution of the flow effect caused by shear-dependent RBC aggregation to NIR spectroscopic signals. Neuroimage (2006) 1.52
Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation. J Biol Chem (2013) 1.50
Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J Biol Chem (2009) 1.44
Evidence against strong correlation between chest symptoms and ischemic coronary changes after subcutaneous sumatriptan injection. Intern Med (2002) 1.40
Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem (2005) 1.34
Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc Natl Acad Sci U S A (2010) 1.24
Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain (2008) 1.22
Slowly progressive spread of the stroke-like lesions in MELAS. Neurology (2003) 1.21
Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J Clin Invest (2008) 1.19
Regeneration of the central nervous system using endogenous repair mechanisms. J Neurochem (2007) 1.17
Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol (2006) 1.12
Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17. Neurobiol Dis (2008) 1.12
Control of brain capillary blood flow. J Cereb Blood Flow Metab (2012) 1.12
Evaporation-induced coating of hydrous ruthenium oxide on mesoporous silica nanoparticles to develop high-performance supercapacitors. Small (2013) 1.07
Determination of editors at the novel A-to-I editing positions. Neurosci Res (2008) 1.06
Resident endothelial cells surrounding damaged arterial endothelium reendothelialize the lesion. Arterioscler Thromb Vasc Biol (2010) 1.06
Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy. Clin Rev Allergy Immunol (2012) 1.05
Oxidative metabolism in cultured rat astroglia: effects of reducing the glucose concentration in the culture medium and of D-aspartate or potassium stimulation. J Cereb Blood Flow Metab (2006) 1.02
Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle Nerve (2014) 1.01
Accelerating progress in induced pluripotent stem cell research for neurological diseases. Ann Neurol (2012) 1.01
Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Medicine (Baltimore) (2015) 1.01
N88S seipin mutant transgenic mice develop features of seipinopathy/BSCL2-related motor neuron disease via endoplasmic reticulum stress. Hum Mol Genet (2011) 1.01
Overlooked non-motor symptoms in myasthenia gravis. J Neurol Neurosurg Psychiatry (2012) 0.99
Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy. J Biol Chem (2013) 0.99
The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: rationale and design. Hypertens Res (2005) 0.98
Oscillating neuro-capillary coupling during cortical spreading depression as observed by tracking of FITC-labeled RBCs in single capillaries. Neuroimage (2011) 0.97
Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model. Biochem Biophys Res Commun (2010) 0.97
Group A PP2Cs evolved in land plants as key regulators of intrinsic desiccation tolerance. Nat Commun (2013) 0.97
Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. Clin Neurol Neurosurg (2009) 0.96
Epidemiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo) (2012) 0.95
Dually supplied T-junctions in arteriolo-arteriolar anastomosis in mice: key to local hemodynamic homeostasis in normal and ischemic states? Stroke (2009) 0.95
Astroglial pentose phosphate pathway rates in response to high-glucose environments. ASN Neuro (2012) 0.94
Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome. Arch Neurol (2012) 0.94
Camptocormia in Japanese patients with Parkinson's disease: a multicenter study. Mov Disord (2011) 0.94
Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. J Neuroimmunol (2005) 0.92
RBC velocities in single capillaries of mouse and rat brains are the same, despite 10-fold difference in body size. Brain Res (2010) 0.92
Distribution and origin of TRPV1 receptor-containing nerve fibers in the dura mater of rat. Brain Res (2007) 0.91
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol Brain (2013) 0.91
Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats. J Cereb Blood Flow Metab (2005) 0.91
II. Cerebral infarction/transient ischemic attack (TIA). J Stroke Cerebrovasc Dis (2011) 0.91
Early aggressive treatment strategy against myasthenia gravis. Eur Neurol (2010) 0.91
Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure. Brain Res (2011) 0.90
G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res (2006) 0.90
Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS One (2012) 0.90
Capillary remodeling and collateral growth without angiogenesis after unilateral common carotid artery occlusion in mice. Microcirculation (2011) 0.90
Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A. Neurobiol Dis (2012) 0.89
Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease. J Neurol Sci (2008) 0.88
Three types of striational antibodies in myasthenia gravis. Autoimmune Dis (2011) 0.88
Electrochemical synthesis of mesoporous Pt-Au binary alloys with tunable compositions for enhancement of electrochemical performance. J Am Chem Soc (2012) 0.87
Reactive oxygen species generated by mitochondrial injury in human brain microvessel endothelial cells. Clin Hemorheol Microcirc (2006) 0.87
[Anti-NMDAR encephalopathy: treatment]. Rinsho Shinkeigaku (2008) 0.86
Effective mesopore tuning using aromatic compounds in the aerosol-assisted system of aluminium organophosphonate spherical particles. Dalton Trans (2010) 0.86
Activation of extracellular signal-regulated kinase in the trigeminal ganglion following both treatment of the dura mater with capsaicin and cortical spreading depression. Neurosci Res (2013) 0.86
Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia. Brain Res (2009) 0.85
Clinical features and varieties of non-motor fluctuations in Parkinson's disease: a Japanese multicenter study. Parkinsonism Relat Disord (2012) 0.84
Classification of myasthenia gravis based on autoantibody status. Arch Neurol (2007) 0.83
Long-term adaptation of cerebral hemodynamic response to somatosensory stimulation during chronic hypoxia in awake mice. J Cereb Blood Flow Metab (2013) 0.83
Measuring the vascular diameter of brain surface and parenchymal arteries in awake mouse. Adv Exp Med Biol (2013) 0.83
Initial oligemia with capillary flow stop followed by hyperemia during K+-induced cortical spreading depression in rats. J Cereb Blood Flow Metab (2005) 0.83
Characterization of inclusion bodies with cytoprotective properties formed by seipinopathy-linked mutant seipin. Hum Mol Genet (2011) 0.83
Astrocytes and pericytes cooperatively maintain a capillary-like structure composed of endothelial cells on gel matrix. Brain Res (2011) 0.83
Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study. BMJ Open (2011) 0.83
Clinical and immunological differences between early and late-onset myasthenia gravis in Japan. J Neuroimmunol (2010) 0.83
Topical naphazoline in the treatment of myasthenic blepharoptosis. Muscle Nerve (2011) 0.82
Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis. J Neuroimmunol (2013) 0.82
Differential diagnosis between intracranial dissemination of spinal cord astrocytoma and paraneoplastic limbic encephalitis. Intern Med (2012) 0.82
Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis. J Neuroimmunol (2011) 0.82
A561C polymorphism of E-selectin is associated with ischemic cerebrovascular disease in the Japanese population without diabetes mellitus and hypercholesterolemia. Brain Res (2006) 0.82
Developmental and circulatory profile of the diploic veins. Microvasc Res (2010) 0.81
Astrogliopathy as a loss of astroglial protective function against glycoxidative stress under hyperglycemia. Rinsho Shinkeigaku (2012) 0.81
Direct growth of cobalt hydroxide rods on nickel foam and its application for energy storage. Chemistry (2014) 0.81
REM sleep behavior disorder in Japanese patients with Parkinson's disease: a multicenter study using the REM sleep behavior disorder screening questionnaire. J Neurol (2012) 0.81
Corticobasal degeneration as cause of progressive non-fluent aphasia: clinical, radiological and pathological study of an autopsy case. Neuropathology (2006) 0.81
Direct synthesis of nanoporous carbon nitride fibers using Al-based porous coordination polymers (Al-PCPs). Chem Commun (Camb) (2011) 0.81
Is surgical intervention safe and effective in the treatment of myasthenic blepharoptosis? A multicenter survey in Japan. Eur Neurol (2014) 0.81
Synthesis of nanoporous carbon-cobalt-oxide hybrid electrocatalysts by thermal conversion of metal-organic frameworks. Chemistry (2014) 0.81
Long-term, repeated measurements of mouse cortical microflow at the same region of interest with high spatial resolution. Brain Res (2010) 0.81
Breakthrough and future: nanoscale controls of compositions, morphologies, and mesochannel orientations toward advanced mesoporous materials. Chem Rec (2009) 0.81
Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. J Neurol (2011) 0.80
Autoimmune versus oligodendrogliopathy: the pathogenesis of multiple sclerosis. Arch Immunol Ther Exp (Warsz) (2010) 0.80
Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period. Headache (2006) 0.80
A high-speed passive-matrix electrochromic display using a mesoporous TiO2 electrode with vertical porosity. Angew Chem Int Ed Engl (2010) 0.80
I. Stroke in general. J Stroke Cerebrovasc Dis (2011) 0.80
Quality of life in purely ocular myasthenia in Japan. BMC Neurol (2014) 0.80
[Neurological progression and clinical outcome of branch atheromatous disease (results from the J-BAD registry)]. Rinsho Shinkeigaku (2010) 0.80
[Recent concept of limbic encephalitis: progress in anti-NMDA receptor encephalitis]. Nihon Rinsho Meneki Gakkai Kaishi (2013) 0.80
An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease. J Neural Transm (Vienna) (2013) 0.79
Suppressive effect of chronic peroral topiramate on potassium-induced cortical spreading depression in rats. Cephalalgia (2012) 0.79
Prevalence and clinical features of asymptomatic peripheral artery disease in Japanese stroke patients. J Stroke Cerebrovasc Dis (2011) 0.79
Formation of mesoporous oxide fibers in polycarbonate confined spaces. Chem Commun (Camb) (2009) 0.79